The World Health Organization (WHO) has recommended the use of GLP-1-based medications, such as Ozempic and Wegovy, in the treatment of obesity, emphasizing that they should be combined with a healthy diet, physical exercise, and medical monitoring. WHO has urged pharmaceutical companies to reduce prices and expand production to make these therapies accessible even in low-income countries. Although these medications are already well established in developed countries, WHO warns that global access remains limited, estimating that by 2030, less than 10% of people who could benefit from them will have access.
The new WHO therapeutic guideline includes a conditional recommendation for the use of GLP-1, considering the limited data on long-term efficacy and safety. WHO suggests differentiated pricing and voluntary licenses to allow other manufacturers to produce these medications. The expiration of patents for semaglutide, the active ingredient in Ozempic and Wegovy, will allow the emergence of generic medications, which could reduce prices. However, logistical challenges and the need to prepare health systems for the distribution of these medications remain significant obstacles.
The new WHO therapeutic guideline includes a conditional recommendation for the use of GLP-1, considering the limited data on long-term efficacy and safety. WHO suggests differentiated pricing and voluntary licenses to allow other manufacturers to produce these medications. The expiration of patents for semaglutide, the active ingredient in Ozempic and Wegovy, will allow the emergence of generic medications, which could reduce prices. However, logistical challenges and the need to prepare health systems for the distribution of these medications remain significant obstacles.
Sources
Latest News
18:16
The Bulgarian government dismantled a cyberespionage operation. The hackers stole at least 130 GB of official documents from government administration networks
18:13
The Hutchinson factory in Brașov County is preparing to lay off 112 employees during November–December 2026
18:01
Pakistani businessman sentenced to 27 and a half years in prison for a plot to assassinate American leaders
17:57
Debate at the European Parliament: Dan Nica calls for lower energy prices and funding for Romanian industry / “Romanians pay the most expensive electricity in the EU”
17:53
EU opens first security forum with Mediterranean partners, focusing on maritime routes and counterterrorism
See more news